Press release
Gout Therapeutics Market Size Forecasted To Achieve $5.03 Billion By 2029 With Steady Growth
Gout Therapeutics Market Size
What Is the Gout Therapeutics Market Size and Projected Growth Rate?
In recent times, the market size for gout therapeutics has seen considerable expansion. It's poised to increase from $2.88 billion in 2024 to $3.23 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.2%. Factors contributing to this growth during the historical period include a rise in the occurrence of gout, shifts in lifestyle and diet, high incidences of blood pressure and diabetes, the emergence of xanthine oxidase inhibitors, along with initiatives taken to educate patients.
Expectations are high for a quick expansion in the gout therapeutics market size in the upcoming years. The projected growth for this market is at a compound annual growth rate (CAGR) of 11.7%, reaching $5.03 billion in 2029. Contributing factors to the anticipated growth during the forecast period include increased health care spending, advancement in drug delivery systems, the emergence of new therapies, government-led initiatives for chronic disease management, and support from patient advocacy groups. Major trends going into the forecast period include fresh developments in drug discovery, the approval of innovative drugs, tailored medicine approaches, the rise of telehealth services for managing gout, and ongoing research in therapies that lower urate.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12118
What Are the Major Segments in the Gout Therapeutics Market?
The gout therapeutics market covered in this report is segmented -
1) By Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroid, Diuretics
2) By Treatment: Xanthine Oxidase Inhibitor, Uricosuria Medication
3) By Disease Condition: Acute, Chronic
4) By End-Users: Hospitals, Specialty Clinics, Other End Users
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Traditional NSAIDs, Selective COX-2 Inhibitors
2) By Corticosteroid: Oral Corticosteroids, Injectable Corticosteroids
3) By Diuretics: Thiazide Diuretics, Loop Diuretics
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12118&type=smp
What Are The Driving Gout Therapeutics Market Evolution?
The escalation in gout incidents is foreseen to fuel the advance of the gout therapeutics market. Gout is an inflammatory arthritis condition that triggers pain and inflammation in the joints. The treatment for gout involves alleviating pain, inflammation, and soreness in the joints. Consequently, the swelling occurrence of gout is projected to amplify sales in the gout therapeutics market. For instance, in June 2024, the Australian Institute of Health and Welfare, an American government agency, announced that gout was the underlying cause in 573 fatalities in Australia in 2022, which correlates to 2.2 deaths for every 100,000 individuals. Hence, the escalating prevalence of gout is leading the progression of the gout therapeutics market.
Which Firms Dominate The Gout Therapeutics Market Segments?
Major companies operating in the gout therapeutics market include Sanofi-Aventis, AstraZeneca plc, LG Chem Ltd., GlaxoSmithKline Plc, Takeda Pharmaceuticals Co. Ltd., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Sandoz, Eisai Co. Ltd., Horizon Pharma Plc, Jiangsu HengRui Medicine Co. Ltd., Hikma Pharmaceuticals plc, Swedish Orphan Biovitrum AB, JW Pharmaceutical Corp, Lannett Company Inc, BioCryst Pharmaceuticals Inc., Selecta Biosciences Inc., Rigel Pharmaceuticals Inc., CymaBay Therapeutics Inc., GeneScience Pharmaceuticals Co. Ltd., Shanton Pharma
What Trends Are Expected to Dominate the Gout Therapeutics Market in the Next 5 Years?
One prominent trend emerging in the gout therapeutics market is product innovation. Many well-established companies in this market are continually designing novel treatments in order to maintain their standings. For instance, US-based pharmaceutical company, Synlogic Inc., introduced a new gout treatment medication named SYNB2081 in August 2022. This drug candidate is a synthetic biotic engineered to reduce uric acid levels and is the second clinical drug developed as a result of the joint research collaboration between Synlogic and Ginkgo, another biotech firm based in the US.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/gout-therapeutics-global-market-report
Which Is The Largest Region In The Gout Therapeutics Market?
North America was the largest region in the gout therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gout therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Gout Therapeutics Market?
2. What is the CAGR expected in the Gout Therapeutics Market?
3. What Are the Key Innovations Transforming the Gout Therapeutics Industry?
4. Which Region Is Leading the Gout Therapeutics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gout Therapeutics Market Size Forecasted To Achieve $5.03 Billion By 2029 With Steady Growth here
News-ID: 3996988 • Views: …
More Releases from The Business Research Company
Increasing Demand For Personal Care And Cosmetic Products Drives Coconut Oil Mar …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
How Large Will the Coconut Oil Market Size By 2025?
In the last few years, the coconut oil market has experienced substantial growth. The market size is projected to rise from $5.03 billion in 2024 to $5.49 billion in 2025, which is an annual compound growth rate (CAGR) of 9.2%. This growth in the…
Driving Cloud Security Market Growth in 2025: The Role of Countering The Surge I …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Cloud Security Market Size Growth Forecast: What to Expect by 2025?
The size of the cloud security market has notably increased over the past few years. The market is projected to expand from a value of $17.11 billion in 2024 to reach $19.71 billion in 2025, representing a compound annual growth rate (CAGR) of…
Comprehensive Cloud Based Contact Center Market Forecast 2025-2034: Growth Trend …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Cloud Based Contact Center Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The expansion in the cloud based contact center market has been substantial in the past few years. Its market size is projected to rise from $26.36 billion in 2024 to $31.04 billion in 2025, escalating at a compound…
Explosive Growth In The Consumer Electronics Fuels Circuit Protection Market: Po …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Expected CAGR for the Circuit Protection Market Through 2025?
In recent times, the circuit protection market has experienced significant expansion. The market, which was valued at $54.5 billion in 2024, is projected to rise to $59.88 billion in 2025, with a compound annual growth rate (CAGR) of 9.9%. Factors contributing to…
More Releases for Gout
Global Gout Drugs Market Analysis (2020-2025)
Global Info Research offers a latest published report on Gout Drugs Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Gout Drugs Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/reports/371311/gout-drugs
Market…
Gout Therapeutics Market Emerging Trends And Forecast By 2025
Global Gout Therapeutics Market: Snapshot
The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications.
Patients with multiple episodes of severe gout attacks every year or with…
Gout Therapeutics Market - Growth Management 2017-2025
Global Gout Therapeutics Market: Snapshot
The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications.
Request Sample Copy of the Report @
https://www.tmrresearch.com/sample/sample?flag=B&rep_id=2549
Patients with multiple episodes of…
Gout Therapeutics Market Moderately consolidated by 2025
Global Gout Therapeutics Market: Snapshot
The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications.
Patients with multiple episodes of severe gout attacks every year or with…
Gout Therapeutics Market - Future Growth & Forecast 2017-2025
Global Gout Therapeutics Market: Overview
Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries. But in the recent times, especially in the U.S., the prevalence of gout has increased to greater extents, which is a reflection of growing population with obesity, smoking habits, and increased intake of alcohol. Increased level of uric acid in the…
Gout Therapeutics - Emerging Markets in Developing Countries
Qyresearchreports include new market research report Gout Therapeutics to its huge collection of research reports.
The global market for Gout Therapeutics is discussed in detail within a new research study added recently to QYResearchReports.com. The report has been carefully examined both qualitatively and quantitatively and the results are revealed in the research report for the forecast period of 2017 to 2022. In addition to this, the various drivers and restraints, regulatory…
